MEDICINE FOR REPAIRING, REGENERATING AND TREATING INTERNAL ORGAN TISSUE BY NOVEL BENZOISOFRANONE DERIVATIVE
PROBLEM TO BE SOLVED: To provide a novel benzoisofranone derivative as a medicine which acts on a response by gamma interferon between an epithelial cell and a stroma cell to induce the repair and regeneration of an internal organ tissue after the tissue concerned is damaged; to provide a novel benz...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | TANAKA TETSUAKI ISHIBASHI MICHIO KOJIMA NAOTO |
| description | PROBLEM TO BE SOLVED: To provide a novel benzoisofranone derivative as a medicine which acts on a response by gamma interferon between an epithelial cell and a stroma cell to induce the repair and regeneration of an internal organ tissue after the tissue concerned is damaged; to provide a novel benzoisofranone derivative as a medicine which acts on a response by lymphotoxin alpha between an epithelial cell and a stroma cell to induce the repair and regeneration of an internal organ tissue after the tissue concerned is damaged; and to provide a novel benzoisofranone derivative as a medicine which modifies a responsive reaction in a process, in which a cell is damaged by TGF-beta 1, to induce the repair and regeneration of an internal organ tissue after the tissue concerned is damaged.SOLUTION: The novel benzoisofranone derivative, which has the action to modify a process in which a cell is damaged, is a medicine for repairing, regenerating and treating an internal organ tissue. The novel benzoisofranone derivative; which has the action to modify a process in which a cell is damaged, together with a macrophage or a tissue-effector cell, is a medicine for repairing, regenerating and treating an internal organ tissue. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2012171907A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2012171907A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2012171907A3</originalsourceid><addsrcrecordid>eNqNjMEKglAQRd20iOofhtYFagtxOepoEzZPxpdQG5F4bYoS7P_pQX1Aq3sPnHvnwf1IBecsBKVRUGqQlaXa-FqRkKL1BCgFWKUvsFhSwRqMVihguW1PBNkZxHRUQ0ZyMdyaUlGM_y1IufPLjpbB7DY8Jrf65SJYl2Tz_daNr95N43B1T_fuD00cRnGURGmY4O4v6QM6djcV</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MEDICINE FOR REPAIRING, REGENERATING AND TREATING INTERNAL ORGAN TISSUE BY NOVEL BENZOISOFRANONE DERIVATIVE</title><source>esp@cenet</source><creator>TANAKA TETSUAKI ; ISHIBASHI MICHIO ; KOJIMA NAOTO</creator><creatorcontrib>TANAKA TETSUAKI ; ISHIBASHI MICHIO ; KOJIMA NAOTO</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide a novel benzoisofranone derivative as a medicine which acts on a response by gamma interferon between an epithelial cell and a stroma cell to induce the repair and regeneration of an internal organ tissue after the tissue concerned is damaged; to provide a novel benzoisofranone derivative as a medicine which acts on a response by lymphotoxin alpha between an epithelial cell and a stroma cell to induce the repair and regeneration of an internal organ tissue after the tissue concerned is damaged; and to provide a novel benzoisofranone derivative as a medicine which modifies a responsive reaction in a process, in which a cell is damaged by TGF-beta 1, to induce the repair and regeneration of an internal organ tissue after the tissue concerned is damaged.SOLUTION: The novel benzoisofranone derivative, which has the action to modify a process in which a cell is damaged, is a medicine for repairing, regenerating and treating an internal organ tissue. The novel benzoisofranone derivative; which has the action to modify a process in which a cell is damaged, together with a macrophage or a tissue-effector cell, is a medicine for repairing, regenerating and treating an internal organ tissue.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120910&DB=EPODOC&CC=JP&NR=2012171907A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120910&DB=EPODOC&CC=JP&NR=2012171907A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TANAKA TETSUAKI</creatorcontrib><creatorcontrib>ISHIBASHI MICHIO</creatorcontrib><creatorcontrib>KOJIMA NAOTO</creatorcontrib><title>MEDICINE FOR REPAIRING, REGENERATING AND TREATING INTERNAL ORGAN TISSUE BY NOVEL BENZOISOFRANONE DERIVATIVE</title><description>PROBLEM TO BE SOLVED: To provide a novel benzoisofranone derivative as a medicine which acts on a response by gamma interferon between an epithelial cell and a stroma cell to induce the repair and regeneration of an internal organ tissue after the tissue concerned is damaged; to provide a novel benzoisofranone derivative as a medicine which acts on a response by lymphotoxin alpha between an epithelial cell and a stroma cell to induce the repair and regeneration of an internal organ tissue after the tissue concerned is damaged; and to provide a novel benzoisofranone derivative as a medicine which modifies a responsive reaction in a process, in which a cell is damaged by TGF-beta 1, to induce the repair and regeneration of an internal organ tissue after the tissue concerned is damaged.SOLUTION: The novel benzoisofranone derivative, which has the action to modify a process in which a cell is damaged, is a medicine for repairing, regenerating and treating an internal organ tissue. The novel benzoisofranone derivative; which has the action to modify a process in which a cell is damaged, together with a macrophage or a tissue-effector cell, is a medicine for repairing, regenerating and treating an internal organ tissue.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjMEKglAQRd20iOofhtYFagtxOepoEzZPxpdQG5F4bYoS7P_pQX1Aq3sPnHvnwf1IBecsBKVRUGqQlaXa-FqRkKL1BCgFWKUvsFhSwRqMVihguW1PBNkZxHRUQ0ZyMdyaUlGM_y1IufPLjpbB7DY8Jrf65SJYl2Tz_daNr95N43B1T_fuD00cRnGURGmY4O4v6QM6djcV</recordid><startdate>20120910</startdate><enddate>20120910</enddate><creator>TANAKA TETSUAKI</creator><creator>ISHIBASHI MICHIO</creator><creator>KOJIMA NAOTO</creator><scope>EVB</scope></search><sort><creationdate>20120910</creationdate><title>MEDICINE FOR REPAIRING, REGENERATING AND TREATING INTERNAL ORGAN TISSUE BY NOVEL BENZOISOFRANONE DERIVATIVE</title><author>TANAKA TETSUAKI ; ISHIBASHI MICHIO ; KOJIMA NAOTO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2012171907A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>TANAKA TETSUAKI</creatorcontrib><creatorcontrib>ISHIBASHI MICHIO</creatorcontrib><creatorcontrib>KOJIMA NAOTO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TANAKA TETSUAKI</au><au>ISHIBASHI MICHIO</au><au>KOJIMA NAOTO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MEDICINE FOR REPAIRING, REGENERATING AND TREATING INTERNAL ORGAN TISSUE BY NOVEL BENZOISOFRANONE DERIVATIVE</title><date>2012-09-10</date><risdate>2012</risdate><abstract>PROBLEM TO BE SOLVED: To provide a novel benzoisofranone derivative as a medicine which acts on a response by gamma interferon between an epithelial cell and a stroma cell to induce the repair and regeneration of an internal organ tissue after the tissue concerned is damaged; to provide a novel benzoisofranone derivative as a medicine which acts on a response by lymphotoxin alpha between an epithelial cell and a stroma cell to induce the repair and regeneration of an internal organ tissue after the tissue concerned is damaged; and to provide a novel benzoisofranone derivative as a medicine which modifies a responsive reaction in a process, in which a cell is damaged by TGF-beta 1, to induce the repair and regeneration of an internal organ tissue after the tissue concerned is damaged.SOLUTION: The novel benzoisofranone derivative, which has the action to modify a process in which a cell is damaged, is a medicine for repairing, regenerating and treating an internal organ tissue. The novel benzoisofranone derivative; which has the action to modify a process in which a cell is damaged, together with a macrophage or a tissue-effector cell, is a medicine for repairing, regenerating and treating an internal organ tissue.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_JP2012171907A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | MEDICINE FOR REPAIRING, REGENERATING AND TREATING INTERNAL ORGAN TISSUE BY NOVEL BENZOISOFRANONE DERIVATIVE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T09%3A22%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TANAKA%20TETSUAKI&rft.date=2012-09-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2012171907A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |